AI shows promise for predicting and supporting walking and balance problems, but current research is early and not yet strong enough to change MS care on its own.
Researchers looked at 18 studies using AI to study walking and balance in stroke, Parkinson's disease, and a few in MS. Most work used 'machine learning' (a way computers learn from data) to predict things like who might fall or how someone will recover walking. The studies mostly came from Asia and focused on people after stroke; only a small number included people with MS. Common AI tools were algorithms with names like Random Forest and Support Vector Machine — think of these as different recipes a computer uses to make predictions based on walking data. Importantly, none of the studies tested their AI on new, independent groups of people the way you would test a new medicine, so we don’t know how well the results work in the real world.
People with MS and their caregivers should care because walking and balance problems are common in MS and these tools aim to predict falls or recovery, which could help with planning care. Physical therapists and neurologists should pay attention because AI could become a tool to personalize rehabilitation, like adjusting therapy based on a person’s predicted progress. Think of AI like a new GPS for rehab: it might help find a better route, but right now the map is incomplete and hasn’t been tested on many roads. Care teams might use AI ideas to guide monitoring (for example, watching for changes in walking patterns), but they should not rely on these tools alone. MS patients who are curious can ask their care team whether any local tests or devices have been properly validated before trying them.
The studies reviewed had important limits: most did not include many people with MS, and none tested their AI tools on separate, independent groups, so their accuracy may be overstated. Because of these limits, the findings are best seen as early signs of promise, not proof that AI tools are ready for routine use. Always check with your healthcare team before using or trusting any AI-based device or app for walking and balance.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More6/1/2026
Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n
Read More5/29/2026
Study found kids who had tonsil/adenoid removal had higher odds of MS and about twice the relapse ra
Read More5/28/2026
Study finds stronger breathing-linked brain pulsations and fluid flow changes early in MS tied to sy
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.